Glucagon-Like Peptide 1 Agonist Use in an Adult With Cystic Fibrosis–Related Diabetes and Metabolic Syndrome
This case highlights the potential benefits of glucagon-like peptide 1 receptor agonists in CFRD with metabolic syndrome and emphasizes the need for further investigation.
Authors
- Roger Auth (ORCID: https://orcid.org/0000-0002-1265-6379)
- Kevin J. Scully (ORCID: https://orcid.org/0000-0001-7886-9871)
- Maragret Putnam
- Brian Dougherty (ORCID: https://orcid.org/0000-0002-0093-1142)
Institutions
- Rhode Island Department of Health (US)
- Brown University (US)
- Massachusetts General Hospital (US)
Publication Details
- Journal
- AACE Endocrinology and Diabetes
- Published
- 2025-05-16
- DOI
- https://doi.org/10.1016/j.aed.2025.03.011
- Citations
- 1
- Primary Topic
- Cystic Fibrosis Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 1.52